🇺🇸 FDA
Patent

US 10016437

Drug combinations and uses in treating a coughing condition

granted A61KA61K31/137A61K31/138

Quick answer

US patent 10016437 (Drug combinations and uses in treating a coughing condition) held by Infirst Healthcare Limited expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/137, A61K31/138, A61K31/522, A61K45/06